|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Osiris Therapeutics, Inc. (OSIR) |
|
|
$18.99 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
34,453,000 |
| Market
Cap: |
654.26(M) |
| Last
Volume: |
115,569 |
Avg
Vol: |
54,112 |
| 52
Week Range: |
$18.99 - $18.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Danilkovitch Alla |
Chief Scientific Officer |
• – – |
2019-04-17 |
4 |
D |
$19.00 |
$178,125 |
D/D |
(9,375) |
0 |
|
- |
|
| Keefer Jason |
Chief Commercial Officer |
• – – |
2019-04-17 |
4 |
D |
$19.00 |
$76,000 |
D/D |
(4,000) |
0 |
|
- |
|
| Friedli Peter |
Director |
– • – |
2019-04-17 |
4 |
D |
$19.00 |
$87,514,969 |
I/I |
(4,606,051) |
0 |
|
- |
|
| Friedli Peter |
Director |
– • – |
2019-04-17 |
4 |
D |
$19.00 |
$193,883,676 |
D/D |
(10,204,404) |
0 |
|
- |
|
| Venturetec Inc |
BENEFICIAL OWNER |
– – – |
2018-07-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,000,000) |
0 |
|
- |
|
| Venturetec Inc |
10% Owner |
– – • |
2018-07-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,103,301) |
3,000,000 |
|
- |
|
| Sommer Uwe |
Director |
– • – |
2017-02-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
108,500 |
|
- |
|
| Dresner David A |
Interim President & CEO |
• – – |
2017-01-25 |
4 |
OE |
$5.12 |
$79,500 |
D/D |
15,000 |
25,000 |
|
- |
|
| Dresner David A |
Interim President & CEO |
• – – |
2017-01-23 |
4 |
OE |
$5.03 |
$25,150 |
D/D |
5,000 |
10,000 |
|
- |
|
| Dresner David A |
Interim President & CEO |
• – – |
2017-01-12 |
4 |
OE |
$4.75 |
$23,750 |
D/D |
5,000 |
5,000 |
|
- |
|
| Debrabandere Lode |
President & CEO |
• – – |
2015-11-20 |
4 |
OE |
$6.84 |
$256,500 |
D/D |
37,500 |
37,500 |
|
- |
|
| Danilkovitch Alla |
Chief Scientific Officer |
• – – |
2015-11-19 |
4 |
OE |
$5.08 |
$20,320 |
D/D |
4,000 |
11,950 |
|
- |
|
| Danilkovitch Alla |
Chief Scientific Officer |
• – – |
2015-08-10 |
4 |
S |
$18.22 |
$44,184 |
D/D |
(2,425) |
7,950 |
|
- |
|
| Danilkovitch Alla |
Chief Scientific Officer |
• – – |
2015-08-10 |
4 |
OE |
$0.40 |
$2,000 |
D/D |
5,000 |
10,375 |
|
- |
|
| Huwyler Yves |
Director |
– • – |
2015-06-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
400 |
|
- |
|
| Huwyler Yves |
Director |
– • – |
2015-06-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
50,672 |
|
- |
|
| Law Gregory Ivan |
Principal Accounting Officer |
• – – |
2015-06-04 |
4 |
B |
$18.83 |
$1,883 |
D/D |
100 |
100 |
2.66 |
- |
|
| Jacoby Philip R Jr |
Chief Financial Officer |
• – – |
2015-05-27 |
4 |
S |
$18.55 |
$371,080 |
D/D |
(20,000) |
12,500 |
|
- |
|
| Jacoby Philip R Jr |
Chief Financial Officer |
• – – |
2015-05-27 |
4 |
OE |
$6.46 |
$147,034 |
D/D |
20,000 |
32,500 |
|
- |
|
| Danilkovitch Alla |
Chief Scientific OfficerOffice |
• – – |
2015-04-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,375 |
|
- |
|
| Neumayer Matthew Paul |
Principal Accounting Officer |
• – – |
2014-05-29 |
4 |
S |
$15.55 |
$7,775 |
D/D |
(500) |
0 |
|
- |
|
| Neumayer Matthew Paul |
Principal Accounting Officer |
• – – |
2014-05-29 |
4 |
OE |
$6.46 |
$3,230 |
D/D |
500 |
500 |
|
- |
|
| Neumayer Matthew Paul |
Principal Accounting Officer |
• – – |
2014-05-27 |
4/A |
S |
$16.10 |
$60,375 |
D/D |
(3,750) |
0 |
|
- |
|
| Neumayer Matthew Paul |
Principal Accounting Officer |
• – – |
2014-05-27 |
4/A |
OE |
$5.08 |
$26,079 |
D/D |
3,750 |
3,750 |
|
- |
|
| Neumayer Matthew Paul |
Principal Accounting Officer |
• – – |
2014-05-27 |
4 |
S |
$16.10 |
$60,375 |
D/D |
(3,750) |
5,875 |
|
- |
|
131 Records found
|
|
Page 1 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
